Fundraising FoxBioBrit — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Alume Biosciences develops nerve illumination technology for surgery, including bevonescein (ALM-488), an injectable peptide that makes nerves glow to help surgeons identify and preserve them during procedures such as head-and-neck and prostate surgery.
BiotechHealthtechMedical DevicesLa Jolla, US
Quyen Nguyen(Co-founder)inRoger Tsien(Co-founder)Kaveri Parker(Executive Officer)inBrett Berman(Executive Officer, Director)inJames Schmidt(Executive Officer)in
BoardKim Kamdar(Director)
ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Larry Mimms(Executive Officer, Director)inMagda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.